Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 2
1968 5
1969 2
1970 10
1971 1
1972 1
1973 4
1974 2
1975 4
1976 12
1977 24
1978 16
1979 14
1980 26
1981 28
1982 58
1983 51
1984 52
1985 60
1986 66
1987 75
1988 69
1989 84
1990 84
1991 83
1992 89
1993 57
1994 55
1995 71
1996 54
1997 64
1998 54
1999 41
2000 54
2001 43
2002 41
2003 20
2004 24
2005 29
2006 40
2007 31
2008 30
2009 27
2010 22
2011 22
2012 22
2013 32
2014 27
2015 15
2016 19
2017 18
2018 12
2019 8
2020 6
2021 9
2022 10
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,841 results

Results by year

Filters applied: . Clear all
Page 1
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.
Padmapriyadarsini C, Szumowski JD, Akbar N, Shanmugasundaram P, Jain A, Bathragiri M, Pattnaik M, Turuk J, Karunaianantham R, Balakrishnan S, Pati S, Kumar AKH, Rathore MK, Raja J, Naidu KR, Horn J, Whitworth L, Sewell R, Ramakrishnan L, Swaminathan S, Edelstein PH. Padmapriyadarsini C, et al. Clin Pharmacol Ther. 2024 Feb;115(2):324-332. doi: 10.1002/cpt.3108. Epub 2023 Dec 11. Clin Pharmacol Ther. 2024. PMID: 37983978 Free PMC article. Clinical Trial.
Verapamil's mycobacterial efflux pump inhibition also limits Mtb growth in macrophages in the absence of antibiotic treatment. ...Moreover, norverapamil:verapamil, R:S verapamil, and R:S norverapamil AUC ratios were all significantly greater than those …
Verapamil's mycobacterial efflux pump inhibition also limits Mtb growth in macrophages in the absence of antibiotic treatment. …
Calcium-channel blocking agents.
Leonard RG, Talbert RL. Leonard RG, et al. Clin Pharm. 1982 Jan-Feb;1(1):17-33. Clin Pharm. 1982. PMID: 6764159 Review.
Calcium-channel blocking agents affect the movement of calcium through these channels in smooth and cardiac muscle; the specific agents in this class differ markedly in their inhibitory effects. Verapamil hydrochloride is useful intravenously for treating supraventricular …
Calcium-channel blocking agents affect the movement of calcium through these channels in smooth and cardiac muscle; the specific agents in t …
Verapamil in migraine prophylaxis--a five-year review.
Solomon GD. Solomon GD. Headache. 1989 Jul;29(7):425-7. doi: 10.1111/j.1526-4610.1989.hed2907425.x. Headache. 1989. PMID: 2668225 Review.
Verapamil is a papaverine derivative calcium channel blocking drug that has been effectively utilized in the prophylaxis of migraine. ...Analysis of this information reveals that verapamil is a safe, well-tolerated and effective agent for migraine prophylaxis....
Verapamil is a papaverine derivative calcium channel blocking drug that has been effectively utilized in the prophylaxis of migraine. …
Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.
McTavish D, Sorkin EM. McTavish D, et al. Drugs. 1989 Jul;38(1):19-76. doi: 10.2165/00003495-198938010-00003. Drugs. 1989. PMID: 2670511 Review.
Although verapamil is a well-established treatment for angina, cardiac arrhythmias and cardiomyopathies, this review reflects current interest in calcium antagonists as anti-hypertensive agents by focusing on the role of verapamil in hypertension. ...Sustained relea …
Although verapamil is a well-established treatment for angina, cardiac arrhythmias and cardiomyopathies, this review reflects current …
Oral verapamil in paroxysmal supraventricular tachycardia recurrence control: a randomized clinical trial.
Shaker H, Jahanian F, Fathi M, Zare M. Shaker H, et al. Ther Adv Cardiovasc Dis. 2015 Feb;9(1):4-9. doi: 10.1177/1753944714553425. Epub 2014 Oct 8. Ther Adv Cardiovasc Dis. 2015. PMID: 25297337 Free article. Clinical Trial.
Patients in the adenosine-only group did not received any other medications but patients in the adenosine/verapamil group received 40 mg verapamil orally immediately after converting the rhythm to sinus rhythm. ...Two patients in the adenosine-only group experienced …
Patients in the adenosine-only group did not received any other medications but patients in the adenosine/verapamil group received 40 …
Effect of verapamil on the pharmacokinetics of pasireotide in healthy volunteers.
Kornberger R, Ting LS, Tripathi AP, Rodrigues H, Nesheiwat D, Passos VQ, Hu K. Kornberger R, et al. J Clin Pharmacol. 2014 Nov;54(11):1263-71. doi: 10.1002/jcph.325. Epub 2014 May 24. J Clin Pharmacol. 2014. PMID: 24788408 Clinical Trial.
Subjects received an oral dose of verapamil 240 mg/d for 10 days (days 15-24). On day 18, subjects also received pasireotide SC 600 mug. ...Exploratory analyses showed a 17% (90% CI, 0.72-0.94) reduction in C(trough) and 31% (0.58-0.82) reduction in C(max) (8 hours post-do …
Subjects received an oral dose of verapamil 240 mg/d for 10 days (days 15-24). On day 18, subjects also received pasireotide SC 600 m …
Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators.
Rosei EA, Dal Palù C, Leonetti G, Magnani B, Pessina A, Zanchetti A. Rosei EA, et al. J Hypertens. 1997 Nov;15(11):1337-44. doi: 10.1097/00004872-199715110-00019. J Hypertens. 1997. PMID: 9383184 Clinical Trial.

Normalization of the diastolic blood pressure (to < or = 90 mmHg or to < or = 95 mmHg with a > or = 10% decrease) was achieved for 69.3% of the verapamil and 66.9% of the chlorthalidone group. A decrease in heart rate (by 5.8%) occurred in members of the verapa

…

Normalization of the diastolic blood pressure (to < or = 90 mmHg or to < or = 95 mmHg with a > or = 10% decrease) was achieved for

…
Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids.
Ahuja RB, Chatterjee P. Ahuja RB, et al. Burns. 2014 Jun;40(4):583-8. doi: 10.1016/j.burns.2013.09.029. Epub 2013 Oct 31. Burns. 2014. PMID: 24182692 Clinical Trial.
A randomized, parallel group and observer blinded comparison with 40 patients (48 scars) was carried out to compare the effects of i/l triamcinolone (T) (22 scars) and verapamil injections (V) (26 scars). 1.5 ml was the maximum indicative volume decided in the study protoc …
A randomized, parallel group and observer blinded comparison with 40 patients (48 scars) was carried out to compare the effects of i/l triam …
Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy.
Parodi O, Neglia D, Sambuceti G, Marabotti C, Palombo C, Donato L. Parodi O, et al. Drugs. 1992;44 Suppl 1:48-55. doi: 10.2165/00003495-199200441-00009. Drugs. 1992. PMID: 1283584 Review.
The study was repeated after 6 months of antihypertensive treatment with the calcium antagonist verapamil or the angiotensin converting enzyme (ACE) inhibitor enalapril in a subgroup of 20 patients as part of a randomised, single-blind clinical trial. This study is still i …
The study was repeated after 6 months of antihypertensive treatment with the calcium antagonist verapamil or the angiotensin converti …
Verapamil and ventricular tachyarrhythmias.
Nguyen NX, Yang PT, Huycke E, Sung RJ. Nguyen NX, et al. Pacing Clin Electrophysiol. 1987 May;10(3 Pt 1):571-8. doi: 10.1111/j.1540-8159.1987.tb04522.x. Pacing Clin Electrophysiol. 1987. PMID: 2440008 Review. No abstract available.
1,841 results